(702) 683-8946

Monday - Friday 9am to 5pm



Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)



CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business


InMed Rockets with INM-901 as Potential Alzheimer's Game-Changer

  • October 24th, 2023

Shares of InMed Pharmaceuticals Inc. (Nasdaq: INM) surged by over 100% in pre-market trading following the company's announcement that it has identified a promising lead candidate, INM-901, for the treatment of Alzheimer's disease, based on highly positive proof-of-concept study results.

InMed said that its cannabinoid analog INM-901 showed early potential in targeting various Alzheimer's-related pathways, including brain neuron protection and improved neuronal function. Preclinical studies also indicated positive trends in cognitive function, locomotor activity, anxiety-based behavior, and sound awareness compared to a placebo group.

The cannabinoid-focused drugmaker is now gearing up for advanced preclinical studies, including drug metabolism and pharmacokinetics, and taking steps toward pharmaceutical drug development.

$INM was trading a $1.58 in pre-market, up $1.00 (+172.41%)


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments

Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13